We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+1.75%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.32B
AUM Growth
+$18.4M
Cap. Flow
+$63.1M
Cap. Flow %
4.78%
Top 10 Hldgs %
33.66%
Holding
527
New
34
Increased
323
Reduced
125
Closed
25

Top Buys

Rank Stock Value
1
IAU icon
iShares Gold Trust
IAU
+$29.1M
2
GLD icon
SPDR Gold Trust
GLD
+$19.8M
3
WMT icon
Walmart Inc
WMT
+$17M
4
GLDM icon
SPDR Gold MiniShares Trust
GLDM
+$13.8M
5
AMAT icon
Applied Materials
AMAT
+$4.96M

Top Sells

Rank Stock Value
1
UGL icon
ProShares Ultra Gold
UGL
+$12.5M
2
AZN icon
AstraZeneca
AZN
+$8.14M
3
AVGO icon
Broadcom
AVGO
+$5.93M
4
MSFT icon
Microsoft
MSFT
+$4.33M
5
APH icon
Amphenol
APH
+$3.63M

Sector Composition

Rank Sector Weight
1 Technology 35.21%
2 Healthcare 22.82%
3 Communication Services 11.05%
4 Consumer Discretionary 8.42%
5 Consumer Staples 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NGNE icon
451
Neurogene
NGNE
$738M
$55.4K ﹤0.01%
2,749
+225
+9% +$4.36K
SI
452
Shoulder Innovations Inc
SI
$403M
$52.3K ﹤0.01%
+3,600
New +$50.1K
LENZ
453
LENZ Therapeutics
LENZ
$158M
$50.8K ﹤0.01%
5,553
+454
+9% +$6.38K
AVXL icon
454
Anavex Life Sciences
AVXL
$316M
$50.5K ﹤0.01%
16,445
+1,886
+13% +$8.17K
KMTS
455
Kestra Medical Technologies
KMTS
$1.64B
$49.8K ﹤0.01%
2,500
+2,000
+400% +$47.1K
FHTX icon
456
Foghorn Therapeutics
FHTX
$394M
$49.7K ﹤0.01%
10,396
+1,181
+13% +$6.48K
AUTL
457
Autolus Therapeutics
AUTL
$564M
$49.1K ﹤0.01%
35,597
+2,910
+9% +$4.42K
ACIU icon
458
AC Immune
ACIU
$267M
$49.1K ﹤0.01%
17,852
+1,490
+9% +$4.63K
NBP
459
NovaBridge Biosciences American Depositary Shares
NBP
$216M
$49K ﹤0.01%
19,919
+2,979
+18% +$9.97K
EOLS icon
460
Evolus
EOLS
$536M
$47.3K ﹤0.01%
11,503
+941
+9% +$4.56K
CABA icon
461
Cabaletta Bio
CABA
$465M
$46K ﹤0.01%
17,083
+1,397
+9% +$3.88K
CCCC icon
462
C4 Therapeutics
CCCC
$480M
$45.5K ﹤0.01%
17,316
+1,524
+10% +$3.59K
CHRS icon
463
Coherus Oncology
CHRS
$181M
$44.8K ﹤0.01%
26,525
+6,829
+35% +$12.1K
SLN
464
Silence Therapeutics
SLN
$641M
$43.9K ﹤0.01%
8,335
-5,318
-39% -$29.3K
OPCH icon
465
Option Care Health
OPCH
$3.57B
$43.1K ﹤0.01%
+1,600
New +$51.9K
EDIT icon
466
Editas Medicine
EDIT
$436M
$42.8K ﹤0.01%
17,323
+1,416
+9% +$3K
OBIO icon
467
Orchestra BioMed
OBIO
$266M
$42.6K ﹤0.01%
10,020
+819
+9% +$3.49K
XRAY icon
468
Dentsply Sirona
XRAY
$2.27B
$41.8K ﹤0.01%
+3,600
New +$44.9K
VYGR icon
469
Voyager Therapeutics
VYGR
$197M
$40.4K ﹤0.01%
10,458
+855
+9% +$3.37K
OABI icon
470
OmniAb
OABI
$497M
$40.1K ﹤0.01%
25,546
+2,089
+9% +$3.77K
ARCT icon
471
Arcturus Therapeutics
ARCT
$216M
$38.9K ﹤0.01%
5,042
+412
+9% +$3.01K
BCYC
472
Bicycle Therapeutics
BCYC
$284M
$38.1K ﹤0.01%
8,222
+682
+9% +$3.9K
RCEL icon
473
Avita Medical
RCEL
$251M
$37K ﹤0.01%
10,000
+5,000
+100% +$21K
DRUG
474
Bright Minds Biosciences
DRUG
$779M
$36.5K ﹤0.01%
+500
New +$40.2K
MSLE
475
Satellos Bioscience
MSLE
$209M
$36K ﹤0.01%
+6,400
New +$62.9K
17 18
19
20 21

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q1 2026 Portfolio in Review

As of Q1 2026, China Universal Asset Management Company held 527 positions worth $1.32B, up 1.4% from $1.3B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

China Universal Asset Management Company deployed $63.1M of net new capital in Q1 2026, opening 34 new positions and adding to 323 existing holdings. Its largest new stake was TJX Companies: 13,200 shares worth $2.11M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 38% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was ProShares Ultra Gold, an estimated $12.5M trimmed.

  • China Universal Asset Management Company's largest Q1 2026 buy was TJX Companies: 13,200 shares worth $2.11M.
  • China Universal Asset Management Company added most to iShares Gold Trust in Q1 2026, an estimated $29.1M increase.
  • China Universal Asset Management Company's biggest Q1 2026 reduction was ProShares Ultra Gold, cutting an estimated $12.5M.
  • China Universal Asset Management Company fully exited ServiceNow in Q1 2026, selling an estimated $2.5M.
  • China Universal Asset Management Company's ten largest holdings make up 34% of its $1.32B portfolio in Q1 2026.
  • China Universal Asset Management Company opened 34 new positions and closed 25 in Q1 2026.
  • China Universal Asset Management Company's portfolio value rose 1.4% quarter-over-quarter to $1.32B.

Based on China Universal Asset Management Company's 13F filing for Q1 2026, filed 28 Apr 2026.